JUN 2013

EyeWorld is the official news magazine of the American Society of Cataract & Refractive Surgery.

Issue link: https://digital.eyeworld.org/i/137624

Contents of this Issue


Page 31 of 74

June 2013 curve she has encountered is assisting patients who have a predisposition for significant inflammation when inserting or removing the device frequently, such as patients with mucous membrane pemphigoid. "It's important for me to treat the inflammation during the time of PROSE treatment to ensure an adequate fit," she said. BostonSight user Rebecca Petris, founder, Dry Eye Company, Poulsbo, Wash., hears from patients who are considering use of PROSE treatment. They contact her because of her dry eye website and discussion groups. She has seen greater interest in the devices since the partner clinics started. She sometimes hears of people who have difficulty initially inserting the device. She also hears of people, especially those with Sjogrens syndrome, who have a build-up on the device and have to remove it several times a day for cleaning. These patients may not be able to wear the lens as long as they would like on a daily basis. Still, she said the patients she speaks with are grateful for the treatment. "The lens is almost miraculous for so many patients," she said. The Boston Foundation for Sight is looking to expand its partner clinics, perhaps including clinics in the Pacific Northwest, the Rockies, the Southeast, and the Midwest, Dr. Jacobs said. They also might look to expand slowly into Canada, Mexico, and Europe. EW EW CORNEA Editors' note: Dr. Jacobs is medical director, Boston Foundation for Sight. The other physicians have no financial interests related to this article. 29 Contact information Hessen: mkubanc1@jhmi.edu Jacobs: djacobs@bostonsight.org Petris: rebecca@dryeyecompany.com Pflugfelder: stevenp@bcm.edu References 1. Schein OD, Rosenthal P, Ducharme C. A gas-permeable scleral contact lens for visual rehabilitation. Am J Ophthalmol 1990; 109(3): 318-22. 2. Baran I, Bradley JA, Alipour F, et al. PROSE treatment of corneal ectasia. Cont Lens Anterior Eye. 2012;35:222-227. 3. Kalwerisky K, Davies B, Mihora L, et al. Use of the Boston Ocular Surface Prosthesis in the management of severe periorbital thermal injuries: A case series of 10 patients. Ophthalmology. 2012;119:516-521. INTRODUCING NEW Femtosecond Cataract Instruments E4929 Daya Femto Trans-Lens Hydrodissection Cannula Uniquely Designed to Help Create a Fluid Wave During Hydrodissection E1789 Hu Femto Incision Spreader Curved Shaft & Micro-Spreader Tip Designed to Easily Insert Through Femtosecond Incisions E0645 Hu Capsule Polisher Designed for Flexibility & Ease of Use in Removing Lens Epithelial Cells E4940 Hu Femto Hydrodissection Cannula Features a Flattened Beveled Tip to Insert Under the Capsule to Direct a Fine Concentrated Fluid Stream During Hydrodissection SEE MORE OF OUR FEMTOSECOND INSTRUMENTATION AT WWW.STORZEYE.COM Patient removing a BostonSight PROSE device Source (all): Boston Foundation for Sight CALL YOUR INSTRUMENT SPECIALIST AT 1-800-338-2020 TO ORDER AND FOR M N FOR MORE INFORMATION INFORMATION F AT ®/™ are trademarks of Bausch & Lomb Incorporated or its afliates. © Bausch & Lomb Incorporated. are trademarks Bausch Lom Incorporated omb m Bausch Lomb Incorporated.

Articles in this issue

Links on this page

Archives of this issue

view archives of Eyeworld - JUN 2013